Technical Analysis for IPA - ImmunoPrecise Antibodies Ltd.

Grade Last Price % Change Price Change
F 0.47 4.98% 0.02
IPA closed up 4.98 percent on Tuesday, November 12, 2024, on 63 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
NR7 Range Contraction 4.98%
NR7-2 Range Contraction 4.98%
Narrow Range Bar Range Contraction 4.98%
Wide Bands Range Expansion 4.98%
Shooting Star Candlestick Bearish 6.82%
NR7 Range Contraction 6.82%
Doji - Bearish? Reversal 6.82%
Wide Bands Range Expansion 6.82%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 10 hours ago
Up 5% about 10 hours ago
Up 3% about 10 hours ago
Up 2% about 10 hours ago
Up 1% about 10 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ImmunoPrecise Antibodies Ltd. Description

ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, Europe, and internationally. Its services include B cell sorting, screening and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multispecies antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, and characterization and validation; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with screening and clone-picking; cryopreservation; affinity measurements, functional assays, and epitope mapping and binning; and modeling, design, and manufacturing of custom antigen. The company has a collaboration with University of Victoria to develop a saliva-based antibody-based test for the detection and screening of COVID-19; Zymeworks Inc. for the development of multiple antibody candidates to fight COVID-19; and National Research Council of Canada's Human Health Therapeutics Research Centre to develop neutralizing PolyTope antibodies against SARS-CoV-2, as well as a research partnership with Mila. ImmunoPrecise Antibodies Ltd. was founded in 1989 and is headquartered in Fargo, North Dakota.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Immunology Antibodies Monoclonal Antibody Antibody Cloning Screening

Is IPA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.6
52 Week Low 0.3503
Average Volume 571,651
200-Day Moving Average 1.09
50-Day Moving Average 0.58
20-Day Moving Average 0.50
10-Day Moving Average 0.44
Average True Range 0.07
RSI (14) 43.82
ADX 25.62
+DI 18.85
-DI 24.32
Chandelier Exit (Long, 3 ATRs) 0.50
Chandelier Exit (Short, 3 ATRs) 0.55
Upper Bollinger Bands 0.64
Lower Bollinger Band 0.36
Percent B (%b) 0.39
BandWidth 55.05
MACD Line -0.05
MACD Signal Line -0.05
MACD Histogram 0.0
Fundamentals Value
Market Cap 12.37 Million
Num Shares 26.3 Million
EPS -0.48
Price-to-Earnings (P/E) Ratio -0.98
Price-to-Sales 2.53
Price-to-Book 1.50
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.54
Resistance 3 (R3) 0.53 0.51 0.53
Resistance 2 (R2) 0.51 0.49 0.51 0.52
Resistance 1 (R1) 0.49 0.48 0.50 0.49 0.52
Pivot Point 0.46 0.46 0.47 0.46 0.46
Support 1 (S1) 0.44 0.44 0.45 0.45 0.42
Support 2 (S2) 0.42 0.43 0.42 0.42
Support 3 (S3) 0.40 0.42 0.41
Support 4 (S4) 0.40